GGrantIndex
← Leaderboards

Mary E. Choi

Yale University

$7,200,453
Attributed
$10,239,182
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,282,063 · 7

By mechanism

R01$10,239,182 · 6
P01$5,042,881 · 1

Top collaborators

Most similar at Yale University

Same institution · by research overlap

Others in their field

Top investigators on “Pathogenesis

Research focus

PathogenesisProteinsPathway InteractionsCellsTissuesEpithelial CellsMediator Of Activation ProteinMediatingSignal TransductionRegulationResponseLungCytokineExperimental ModelsInjurySignal PathwayApoptosisHuman DiseaseFibrosisReceptorCell DeathMitochondriaLung DiseasesExtracellular Matrix

Grant awards (30)

Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers$2,543,097
P01 · FY2025 · HL · contact PI
Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers$2,499,784
P01 · FY2024 · HL · contact PI
Inflammasomes: Regulation and Function in Acute Lung Injury$508,492
R01 · FY2021 · HL · contact PI
Metabolic dysfunction regulates mitophagy-dependent necroptosis in COPD$553,373
R01 · FY2020 · HL
Novel role of RIPK3-dependent necroptosis pathway in lung and kidney fibrosis$523,411
R01 · FY2020 · HL · contact PI
Inflammasomes: Regulation and Function in Acute Lung Injury$508,492
R01 · FY2020 · HL · contact PI
Metabolic dysfunction regulates mitophagy-dependent necroptosis in COPD$553,373
R01 · FY2019 · HL
Novel role of RIPK3-dependent necroptosis pathway in lung and kidney fibrosis$523,411
R01 · FY2019 · HL · contact PI
Inflammasomes: Regulation and Function in Acute Lung Injury$508,492
R01 · FY2019 · HL
Novel role of RIPK3-dependent necroptosis pathway in lung and kidney fibrosis$521,905
R01 · FY2018 · HL · contact PI
Novel role of RIPK3-dependent necroptosis pathway in lung and kidney fibrosis$539,280
R01 · FY2017 · HL
Heme Oxygenase-1/Carbon Monoxide in Lung Vascular Injury$469,346
R01 · FY2017 · HL · contact PI
Heme Oxygenase-1/Carbon Monoxide in Lung Vascular Injury$468,204
R01 · FY2016 · HL · contact PI
Heme Oxygenase-1/Carbon Monoxide in Lung Vascular Injury$399,679
R01 · FY2015 · HL · contact PI
TGF-beta signaling in the kidney$368,663
R01 · FY2014 · DK · contact PI
Heme Oxygenase-1/Carbon Monoxide in sepsis$78,251
R01 · FY2014 · HL · contact PI
TGF-beta signaling in the kidney$195,720
R01 · FY2013 · DK · contact PI
TGF-beta signaling in the kidney$178,435
R01 · FY2013 · DK · contact PI
TGF-beta signaling in the kidney$387,725
R01 · FY2012 · DK · contact PI
TGF-beta signaling in the kidney$445,454
R01 · FY2011 · DK · contact PI
TGF-beta signaling in the kidney$338,502
R01 · FY2009 · DK · contact PI
TGF-beta signaling in the kidney$338,072
R01 · FY2008 · DK · contact PI
TGF-beta signaling in the kidney$293,807
R01 · FY2007 · DK · contact PI
TGF-beta signaling in the kidney$302,635
R01 · FY2006 · DK · contact PI
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY$255,535
R01 · FY2004 · DK
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY$256,495
R01 · FY2003 · DK
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY$257,455
R01 · FY2002 · DK
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY$258,275
R01 · FY2001 · DK
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY$178,203
R01 · FY2000 · DK
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY$28,497
R01 · FY2000 · DK